OR WAIT null SECS
© 2023 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.
November 11, 2021
A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.